§958 Registration requirements

Summary

The Attorney General must register people who want to import or export controlled drugs, but only if the registration fits the public interest and the United States’ treaty duties that were in effect on May 1, 1971. For Schedule I and II drugs, the Attorney General must look at the six public‑interest factors listed in section 823(a) before approving. For importing Schedule III, IV, or V drugs, and for exporting Schedule III or IV drugs, the Attorney General must register applicants unless doing so would conflict with the public interest, using the six factors in section 823(e). The Attorney General must also register importers and exporters of List I chemicals unless registration would conflict with the public interest, while considering the factors in section 823(i). A drug product exempted under section 802(39)(A)(iv) does not need this registration. The Attorney General may deny, suspend, or revoke registrations for public‑interest or treaty reasons. Before doing that, the Attorney General must send an order that explains the reasons and gives the applicant or registrant at least 30 days to appear for a hearing under the federal administrative procedure rules. The Attorney General can immediately suspend a registration if there is an imminent danger to public health or safety. If registrations are suspended or revoked, the Attorney General may seal, seize, sell perishable items, and ultimately forfeit the substances as allowed by law. Registrations last no more than one year. The Attorney General may write rules, charge fees, require separate registrations at each main business location, and must give current bulk manufacturers a chance for a hearing before allowing new bulk imports of Schedule I or II drugs, except in listed emergencies. Registered people may import, export, and possess only what their registration allows and must follow other related laws.